Clinical trials
Clinical clinical trials
Below are recruiting clinical clinical trials, each written for real people, not researchers. We’re tracking 5,431 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07805668Recruiting
Emotional control study for young children
This study looks at emotional and behavioral challenges in children aged 3 to 6 years. It aims to better understand these difficulties to improve support and care.
Pisa, ItalyAges 3–6 - NCT07801001Enrolling by invitation
Zinc supplements for women with polycystic ovary syndrome
This study tests whether taking zinc supplements can improve insulin resistance and reduce symptoms in women with polycystic ovary syndrome (PCOS). If you have PCOS and are not pregnant, you may be able to join.
DhakaAges 18–45 - NCT07800949RecruitingPhase 2
Comparing regular vs narrow dental implants for lower dentures
This study tests whether regular or narrow dental implants work better for supporting a lower denture in people who have no teeth. It may help improve how well the denture fits and feels.
CairoAges 55–65 - NCT07806695RecruitingPhase 1
Understanding insulin production in gestational diabetes
This study looks at how the body makes insulin during pregnancy to understand why some women get gestational diabetes. If you join, you'll have some extra blood tests during pregnancy and after birth to help researchers learn more.
Rochester, MinnesotaAges 20–40 - NCT07806890Recruiting
New 4D ultrasound imaging during left atrial appendage closure
This study tests a new 3D/4D ultrasound technology that creates detailed images of the heart during a left atrial appendage closure procedure. The goal is to see if this imaging tool helps doctors perform the procedure more safely and accurately.
Cleveland, OhioAges 18 years+ - NCT07808229Recruiting
Fallopian tube function assessment and personalized treatment
This study looks at how well the fallopian tubes work and uses that information to choose the best treatment for women struggling to get pregnant. It may help find the right approach for you based on your specific condition.
Beijing, Beijing MunicipalityAges 20–40 - NCT06514313RecruitingPhase 2
Study of a drug combo for children with returning soft tissue sarcoma
This trial tests a combination of three drugs (VIM and VIT) for children and young adults whose soft tissue sarcoma has come back or not responded to previous treatments. The goal is to see if this new combination can help shrink or control the tumor.
Guangzhou, GuangdongAges 2–21 - NCT06515106Recruiting
Living with LGI1 encephalitis: a study on long-term symptoms
This study looks at symptoms, biomarkers, and mechanisms of the chronic phase of LGI1 antibody-mediated encephalitis. It aims to understand what happens after the acute stage and how to better manage long-term effects.
Barcelona, CataloniaAges Any age - NCT07795164RecruitingPhase 3
Study of pemvidutide for liver scarring from MASH
This study tests an investigational medicine called pemvidutide to see if it can reduce liver scarring in people with MASH (a liver condition linked to excess weight and metabolic issues). It may help improve liver health and potentially slow or reverse the condition.
North Little Rock, ArkansasAges 18–75 - NCT07793227RecruitingPhase 3
Testing a new hepatitis A vaccine in healthy people
This trial tests a new hepatitis A vaccine in healthy people aged 1 year and older. It aims to see how well the vaccine prevents hepatitis A and checks for any side effects.
HanoiAges 1 year+ - NCT06519552RecruitingPhase 1
Gene therapy study for adults with MPS type I
This study tests a new gene therapy called JWK008 for adults with MPS type I. The goal is to see if it is safe and can help improve symptoms. You may be able to join if you are 18 or older and have not had serious side effects from enzyme replacement therapy.
Chengdu, SichuanAges 18 years+ - NCT07795450Recruiting
Computer model study for ICU patients
This study uses a computer model to analyze health data from ICU patients to help predict outcomes. It aims to improve care for critically ill patients.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07793383Recruiting
Testing ways to support opioid treatment decisions in the ER
This study is testing different ways to help people with opioid use disorder decide if they want to start medication treatment while they're in the emergency department. It's looking at how to improve the support and guidance given in that setting.
Guilford, ConnecticutAges 18 years+ - NCT07798778RecruitingEarly Phase 1
New drug for advanced prostate cancer that has stopped responding to hormone therapy
This trial tests a new drug called SRT-017 for men with advanced prostate cancer that has stopped responding to standard hormone therapy. The drug targets a marker on cancer cells (PSMA) and may help slow the disease. The study will check if it is safe and effective.
Wuxi, JiangsuAges 18 years+ - NCT07794475RecruitingPhase 1/Phase 2
Trimetazidine for diabetic nerve pain
This trial tests whether the drug trimetazidine can improve nerve damage symptoms in people with type 2 diabetes and diabetic neuropathy. It also looks at how the drug affects a substance in the blood called endothelin-1, which may be involved in nerve damage.
CairoAges 18–65 - NCT07793916Recruiting
Heart device and tricuspid valve function study
This study looks at how heart devices like pacemakers affect the tricuspid valve over time. It uses ultrasound to check valve function and see if the device causes any problems.
Seoul, SeoulAges 19 years+ - NCT07795645Recruiting
AI model training for stomach, heart, and brain diseases
This study is testing an artificial intelligence (AI) system that learns from your medical records to better understand and possibly help with diseases like stomach issues, heart problems, and strokes. It may improve how doctors use information from your visit to guide your care.
BeijingAges 18 years+ - NCT07795502Recruiting
Tracking infections in cancer patients with sepsis
This study watches how infections grow and respond to treatment in cancer patients who may have sepsis. It aims to find better ways to diagnose and monitor sepsis early, which could improve care and outcomes.
Sohag, Sohag GovernorateAges 18 years+ - NCT06478472Recruiting
Orelabrutinib plus rituximab for marginal zone lymphoma
This trial tests a combination of two targeted therapies—oralebrutinib (a pill that blocks a protein in cancer cells) and rituximab (an antibody infusion)—for people with marginal zone lymphoma that has returned or cannot be treated with local therapies. The goal is to see if this combo works well and is safe.
Xiamen, FujianAges 18 years+ - NCT06525909Recruiting
Immune status in chronic hepatitis B
This study looks at how the immune system changes over time in people with chronic hepatitis B. It will help doctors better understand the stages of the disease to guide treatment decisions.
Wuhan, HubeiAges 18–50 - NCT06528197Recruiting
Building a better treatment model for Sjögren's syndrome
This study is building a new model to help doctors treat primary Sjögren's syndrome using a combination of traditional Chinese medicine and Western medicine. It may help find better ways to manage your symptoms.
Beijing, Beijing MunicipalityAges 18–75 - NCT06530004Recruiting
Rituximab for childhood nephrotic syndrome: a follow-up study
This study follows children with nephrotic syndrome (a kidney condition causing swelling) who are being treated for the first time with rituximab. It aims to see how well the medication works long-term.
Xiamen, FujianAges 1–18 - NCT04885985Recruiting
Check a new treatment for blocked leg arteries after procedures
This post-market study follows people with significant below-the-knee artery blockages to see how a treatment performs over time. It may help patients by confirming the safety and ongoing effectiveness of the device used for these leg artery problems.
Beijing, Beijing MunicipalityAges 18–75 - NCT04393389Recruiting
Follow-up study for a drug-coated balloon in leg arteries
This is a post-market follow-up study of a drug-coated balloon used to open blocked leg arteries. It checks how safe the device is and how well it works over time after your procedure.
Halle, Saxony-AnhaltAges 18 years+
Hear when a new Clinical trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for clinical?
- Yes. Clin2 currently lists 5,431 recruiting clinical studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a clinical trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a clinical trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.